Skip to main content

Aeglea BioTherapeutics, Inc. - Common Stock (NQ: AGLE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
September 06, 2017
Form 8-K
Source: SEC/Edgar
July 19, 2017
Form CT ORDER
Source: SEC/Edgar
April 24, 2017
Form DEF 14A
Source: SEC/Edgar
April 20, 2017
Form 8-K
Source: SEC/Edgar
April 20, 2017
Form 8-K
Source: SEC/Edgar
March 23, 2017
Form 8-K
Source: SEC/Edgar
March 22, 2017
Form S-8
Source: SEC/Edgar
March 22, 2017
Form 8-K
Source: SEC/Edgar
March 22, 2017
Form 8-K
Source: SEC/Edgar
March 05, 2017
Form 8-K
Source: SEC/Edgar
February 15, 2017
Form SC 13G
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 01, 2017
Form CT ORDER
Source: SEC/Edgar
December 05, 2016
Form 8-K
Source: SEC/Edgar
November 08, 2016
Form 8-K
Source: SEC/Edgar
October 19, 2016
Form 8-K
Source: SEC/Edgar
August 08, 2016
Form CERTNAS
Source: SEC/Edgar
June 27, 2016
Form CERTNAS
Source: SEC/Edgar
June 12, 2016
Form 8-K
Source: SEC/Edgar
May 18, 2016
Form SC 13G
Source: SEC/Edgar
May 09, 2016
Form SC 13G
Source: SEC/Edgar
May 08, 2016
Form 8-K
Source: SEC/Edgar
April 18, 2016
Form SC 13G
Source: SEC/Edgar
April 17, 2016
Form 8-K
Source: SEC/Edgar
April 17, 2016
Form 3/A
Source: SEC/Edgar
April 13, 2016
Form SC 13G
Source: SEC/Edgar
April 13, 2016
Form 3/A
Source: SEC/Edgar
April 07, 2016
Form CT ORDER
Source: SEC/Edgar
April 06, 2016
Form S-8
Source: SEC/Edgar
April 06, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.